How CAR T-cell Therapy Revolutionizes Lymphoma Treatment
CAR T-cell therapy emerges as a groundbreaking advancement in lymphoma treatment, offering hope for patients with relapsed or refractory blood cancers. By harnessing genetically engineered T-cells, this therapy targets cancer antigens with precision, earning FDA approval for its effectiveness. As research continues to improve accessibility and cost-efficiency, exploring its potential for solid tumors is crucial. […]
3 minute read